CIN- L67120MH1995PLC084899

Login

Login

Generate password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Aarti Drugs Ltd.

NSE : AARTIDRUGSEQ BSE : 524348 ISIN CODE : INE767A01016Industry : Pharmaceuticals

News

  • Aarti Drugs Ltd - Copy of Newspaper Publication 18 Nov 2025 | 19:34 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Earnings Call Transcript 14 Nov 2025 | 18:47 | Dion Global

    Q2 & H1 FY26 Earning Conference Call Transcriptmore...

  • Aarti Drugs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates 14 Nov 2025 | 18:46 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Transcriptmore...

  • Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 10 Nov 2025 | 22:22 | Dion Global

    Recording of Conference Callmore...

  • Aarti Drugs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates 10 Nov 2025 | 22:22 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Link of Recordingmore...

  • Aarti Drugs Ltd - Copy of Newspaper Publication 08 Nov 2025 | 20:59 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publicationmore...

  • Aarti Drugs Ltd - Investor Presentation 07 Nov 2025 | 20:45 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Investor Presentationmore...

  • Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation 07 Nov 2025 | 20:45 | Dion Global

    Q2 and H1 FY 26 Investor Presentationmore...

  • Aarti Drugs Ltd - Press Release 07 Nov 2025 | 20:39 | Dion Global

    Aarti Drugs Limited has informed the Exchange regarding a press release dated 0 titled Q2 & H1 FY26 Business & Financial Performance .more...

  • Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release 07 Nov 2025 | 20:39 | Dion Global

    Press Release - Q2 & H1 FY26 Business and Financial Performancemore...

  • Aarti Drugs Ltd Q2 net profit up 37.48% at Rs 41.78 cr 07 Nov 2025 | 16:32 | Dion Global

    The company reported standalone net profit of Rs 41.78 crore for the quarter ended September 30 2025 as compared to Rs 30.39 crore in the same period...more...

  • Aarti Drugs Ltd - Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30, 2025 07 Nov 2025 | 14:56 | Dion Global

    Financial Results for the quarter and half year ended September 30 2025more...

  • Aarti Drugs Ltd - Financial Results For The Quarter And Half Year Ended September 30 2025 07 Nov 2025 | 14:49 | Dion Global

    Financial Results for the quarter and half year ended September 30 2025more...

  • Aarti Drugs Ltd - Outcome of Board Meeting 07 Nov 2025 | 14:48 | Dion Global

    Aarti Drugs Limited has submitted to the Exchange the financial results for the period ended September 30 2025.more...

  • Aarti Drugs Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 31 Oct 2025 | 20:37 | Dion Global

    Intimation of Quarterly Earning Callmore...

  • Aarti Drugs Ltd - Analysts/Institutional Investor Meet/Con. Call Updates 31 Oct 2025 | 20:37 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Schedule of meetmore...

  • Aarti Drugs Ltd - Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended September 30, 20 31 Oct 2025 | 20:26 | Dion Global

    Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2025 inter alia to consider and appro...more...

  • Aarti Drugs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025 18 Oct 2025 | 19:00 | Dion Global

    As of September 2025 54.72% is owned by Indian Promoters and 45.28% by Public. Institutional holds 12.58% (Insurance Companies 0.08%) and No...more...

  • Aarti Drugs Ltd - General Updates 09 Oct 2025 | 19:04 | Dion Global

    Aarti Drugs Limited has informed the Exchange about Crisil ESG ratingmore...

  • Aarti Drugs Ltd - Crisil ESG Rating 09 Oct 2025 | 19:04 | Dion Global

    Intimation under regulation 30 of SEBI (LODR) 2015 - Crisil ESG Ratingmore...

DOW Jones45473.550.16%
Nasdaq21794.160.43%
S&P 5006496.040.22%
Nikkei 22543643.811.45%
Hang Seng25633.910.85%
Shanghai Composite3826.840.38%
Sensex85267.660.53%
NSE Index26046.950.57%
BSE 1000 11040.150.71%
BSE 100LCTMC9583.110.61%
BSE Auto 61846.660.50%
BSE BasicMat7817.291.84%

Commodity

Gold1282210.61%
Silver1782361.53%
Copper820.15101.12%
Crude Oil64130.66%
Lead192.443.15%
Mentha Oil1067.40.96%
Nickel2480223.38%

Currency

USD/INR 90.39(0.02 %)
GBP/INR 121.06(0.23 %)
EUR/INR 106.08(0.45 %)
JPY/INR 0.58(0.20 %)
CAD/INR 65.60(0.00 %)
HKD/INR 11.61(0.00 %)